The mortality rate for pancreas malignant neoplasms in Japan, measured in standardised rates of female deaths per 100,000 women, is projected to increase incrementally from 15.2 in 2024 to 15.6 by 2028. This reflects a consistent annual increase of approximately 0.66%. The CAGR for the five-year period starting from 2024 is projected to be around 0.66% per year, with these figures indicating a steady rise in mortality rates over the forecasted period.
Future trends to watch for include advancements in early detection and treatment methodologies, any potential changes in healthcare policies, and lifestyle factors that could influence the rate of pancreatic cancer mortality in Japan. Monitoring the impact of these factors will be crucial in understanding and potentially addressing this rising trend.
